Suggestions
Jim Reddoch, PhD
Royalty Pharma
Jim Reddoch, PhD, serves as the Executive Vice President of Investments and Chief Scientific Officer (CSO) at Royalty Pharma, a leading firm in royalty funding for life sciences. With over 25 years of experience in biopharma investing, Dr. Reddoch plays a crucial role in leveraging scientific expertise to identify investment opportunities and trends within the industry.
Professional Background
-
Education: Dr. Reddoch holds a Bachelor of Arts from Furman University and a PhD in Biochemistry and Molecular Genetics from the University of Alabama at Birmingham (UAB). He also completed a postdoctoral fellowship at Yale University.13
-
Career Path: Before joining Royalty Pharma in 2008, he led healthcare research at FBR Capital Markets and worked as a biotechnology analyst at Bank of America and CIBC World Markets. At Royalty Pharma, he has been instrumental in leading the Research and Investments team from 2008 to 2020.125
-
Board Memberships: Dr. Reddoch serves on several boards, including the Leukemia and Lymphoma Society (LLS) and Avillion, a drug development company based in London. He is also part of the External Review Board for the Technology Development Fund at Memorial Sloan Kettering Cancer Center.123
Role at Royalty Pharma
As CSO and EVP of Investments, Dr. Reddoch is responsible for sourcing and analyzing new investment opportunities and partnerships. His role is pivotal in guiding Royalty Pharma's strategic investments in biopharmaceutical innovations, which have included deploying significant capital to advance life science projects.15
Contributions to the Industry
Dr. Reddoch's extensive background in both science and finance has positioned him as a key figure in the biopharmaceutical investment landscape. His leadership at Royalty Pharma reflects a commitment to fostering innovation through strategic funding.13
For more detailed insights into his professional journey, you can find his profile on LinkedIn under the username jim-reddoch-phd-11936610.4
Highlights
Just back to NYC after an awesome few days in the North Cascades for the Timmerman Traverse. Incredible scenery - peaks, glaciers, alpine meadows - and unforgettable comraderie with biotech friends. Some shop talk, and a lot of laughs. And Life Science Cares, Inc. now has $900k+ more for its mission. Thanks to Luke Timmerman for the vision and the mountaineering, and Sarah MacDonald for organizing us! Not too late to make a donation to get us to our $1mil goal.
